Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HMPL-004 in Active Moderate Crohn's Disease
NCT00655733Phase 2Completed
- Sponsor
- Hutchison MediPharma (HMP)
- Start
- Apr 2006
- Primary completion
- Apr 2009
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of andrographolide in Crohn's disease, sponsored by Hutchison MediPharma (HMP). Started Apr 2006; status: completed.
02
Drugs
andrographolide
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT00655733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00655733.